Foghorn Therapeutics Inc. Annual Interest Expense in USD from 2019 to 2021

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Foghorn Therapeutics Inc. quarterly/annual Interest Expense history and growth rate from 2019 to 2021.
  • Foghorn Therapeutics Inc. Interest Expense for the quarter ending September 30, 2022 was $0.000, a 100% decline year-over-year.
  • Foghorn Therapeutics Inc. Interest Expense for the twelve months ending September 30, 2022 was $426K, a 76.3% decline year-over-year.
  • Foghorn Therapeutics Inc. annual Interest Expense for 2021 was $1.91M, a 94.7% increase from 2020.
  • Foghorn Therapeutics Inc. annual Interest Expense for 2020 was $979K, a 81.3% increase from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $1.91M +$927K +94.7% Jan 1, 2021 Dec 31, 2021 10-K/A 2022-08-09
2020 $979K +$439K +81.3% Jan 1, 2020 Dec 31, 2020 10-K/A 2022-08-09
2019 $540K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.